ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nilsson, B.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Nilsson, B.
Related Collections
Right arrowRelated Article

Ann Thorac Surg 1996;61:1157
© 1996 The Society of Thoracic Surgeons

Invited Commentary

Invited Commentary

Bo Nilsson, MDPhD

Department of Clinical Immunology and Transfusion Medicine, University Hospital, Uppsala S-75185, Sweden

The first 20% of the full text of this article appears below.

See also page 1153.

Complement activation appears to be an important contributor to activation of inflammatory cells and platelets during cardiopulmonary bypass. This work confirms that complement activation during cardiopulmonary bypass can be reduced by using heparin-coated cardiopulmonary bypass circuits. It also adds further knowledge about the extent of classic pathway activation in connection . . . [Full Text of this Article]


Related Article

Specific Complement Inhibition With Heparin-Coated Extracorporeal Circuits
Henk te Velthuis, Piet G. M. Jansen, C. Erik Hack, León Eijsman, and Charles R. H. Wildevuur
Ann. Thorac. Surg. 1996 61: 1153-1157. [Abstract] [Full Text]





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1996 by The Society of Thoracic Surgeons.